Aluztra Bio (Global Intellectual Property for Anagrelide) Overview
- Year Founded
-
2014
- Status
-
Acquired/Merged
- Employees
-
1
- Latest Deal Type
-
Asset Purch.
- Financing Rounds
-
1
Aluztra Bio (Global Intellectual Property for Anagrelide) General Information
Description
Global intellectual property of Anagrelide. Anagrelide is a oro-mucosal novel anti-cancer agent and potentially avoid side effects associated with the molecule when administered as an oral capsule.
Contact Information
Corporate Office
- The Old Rectory, Southampton Road
- Landford
- Salisbury SP5 2ED
- England, United Kingdom
Corporate Office
- The Old Rectory, Southampton Road
- Landford
- Salisbury SP5 2ED
- England, United Kingdom
Aluztra Bio (Global Intellectual Property for Anagrelide) Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Aluztra Bio (Global Intellectual Property for Anagrelide) Signals
Aluztra Bio (Global Intellectual Property for Anagrelide) Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Aluztra Bio (Global Intellectual Property for Anagrelide) FAQs
-
When was Aluztra Bio (Global Intellectual Property for Anagrelide) founded?
Aluztra Bio (Global Intellectual Property for Anagrelide) was founded in 2014.
-
Where is Aluztra Bio (Global Intellectual Property for Anagrelide) headquartered?
Aluztra Bio (Global Intellectual Property for Anagrelide) is headquartered in Salisbury, United Kingdom.
-
What is the size of Aluztra Bio (Global Intellectual Property for Anagrelide)?
Aluztra Bio (Global Intellectual Property for Anagrelide) has 1 total employees.
-
What industry is Aluztra Bio (Global Intellectual Property for Anagrelide) in?
Aluztra Bio (Global Intellectual Property for Anagrelide)’s primary industry is Buildings and Property.
-
Is Aluztra Bio (Global Intellectual Property for Anagrelide) a private or public company?
Aluztra Bio (Global Intellectual Property for Anagrelide) is a Private company.
-
What is Aluztra Bio (Global Intellectual Property for Anagrelide)’s current revenue?
The current revenue for Aluztra Bio (Global Intellectual Property for Anagrelide) is .
-
Who are Aluztra Bio (Global Intellectual Property for Anagrelide)’s investors?
Aluztra Bio has invested in Aluztra Bio (Global Intellectual Property for Anagrelide).
-
When was Aluztra Bio (Global Intellectual Property for Anagrelide) acquired?
Aluztra Bio (Global Intellectual Property for Anagrelide) was acquired on 01-Jan-2018.
-
Who acquired Aluztra Bio (Global Intellectual Property for Anagrelide)?
Aluztra Bio (Global Intellectual Property for Anagrelide) was acquired by Arovella Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process